Ascent Industries (ACNT) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 were $42.9 million, down 8.2% year-over-year due to lower volumes and pricing, but gross profit more than doubled to $6.5 million, driven by cost management and operational efficiency.

• Adjusted EBITDA rose to $2.5 million from $(1.5) million, with margin improving to 5.7% from (3.2)% year-over-year.

• Net loss from continuing operations improved to $7.0 million (or $0.69 per share) from $14.7 million (or $1.45 per share) year-over-year, including a $6.2 million non-cash tax charge.

• Leadership credited for rapid cost reductions and operational improvements, with a focus on business development in specialty chemicals.

• Specialty Pipe & Tube divestiture and Munhall facility closure classified as discontinued operations, impacting reported results.

Financial highlights

• Gross profit margin increased to 15.1% from 6.4% year-over-year, reflecting improved efficiency.

• Cash and cash equivalents at September 30, 2024 were $8.5 million, with $57.5 million available under the credit facility and no debt outstanding.

• Operating income for Q3 2024 was $0.5 million, a turnaround from a $15.1 million loss in Q3 2023.

• Repurchased 42,623 shares for $0.4 million during the quarter.

• Nine-month 2024 net sales were $137.2 million, down 9.7% year-over-year, with gross profit for the first nine months rising 304.2% to $14.8 million.

Outlook and guidance

• Management anticipates continued quarter-on-quarter growth, ongoing cash build, and further margin and working capital improvements.

• Cautiously optimistic about improving demand in tubular products and expects revenue growth in specialty chemicals in 2025.

• Capital spending for the remainder of 2024 is expected to be up to $0.8 million.

• Specialty chemicals segment stabilization is ahead of schedule, with plans to look beyond organic growth.